Blog: Depo-Provera

Anapol Weiss Files MDL Petition for Depo-Provera Litigation

Dec 19, 2024

Philadelphia, PA – Anapol Weiss has filed a petition before the United States Judicial Panel on Multidistrict Litigation (JPML) seeking to consolidate all federal lawsuits involving Depo-Provera (Depot Medroxyprogesterone Acetate), a contraceptive injection linked to the development of cerebral meningiomas. The motion was filed on December 10, 2024. The petition requests that the pending cases, currently scattered across multiple federal courts, be transferred for coordinated or consolidated pretrial proceedings. Anapol Weiss proposes the U.S. District Court...

Depo-Provera Lawsuits, Meningioma Tumors, and How to File

Dec 2, 2024

Meningiomas are the most common type of brain tumor, accounting for approximately 30% of all brain tumors, according to the Mayo Clinic. Although most meningiomas are benign, their location and growth can cause significant challenges, particularly when they are deemed inoperable. Recent studies have raised concerns about the potential link between prolonged use of Depo-Provera, a popular injectable contraceptive, and an increased risk of developing meningiomas. This revelation has led to lawsuits alleging that users were...

Progesterone Contraceptive Depo-Provera Linked to Meningioma Brain Tumors

Nov 27, 2024

Emerging research highlights significant risks associated with prolonged use of certain hormonal contraceptives. Studies now reveal troubling links between progesterone-based contraceptives, such as Depo-Provera, and an increased risk of intracranial meningiomas—serious brain tumors that can cause complications, including vision loss. A recent October 2024 study from the University of Cincinnati, along with pivotal research published earlier in Cancers and The BMJ, underscores the need for greater awareness and accountability regarding long-term injectable contraceptive use. October 2024 Study:...

September Study Links Prolonged Depo-Provera Use to Increased Risk of Brain Tumors

Nov 24, 2024

In September 2024, a significant study published in the journal Cancers revealed a troubling link between the prolonged use of Depo-Provera, an injectable contraceptive containing depot medroxyprogesterone acetate (dMPA), and an increased risk of developing cerebral meningiomas. The large-scale case-control study analyzed over 117,000 meningioma cases and more than one million matched controls using data spanning 2006–2022. It found that “injection exposure” to medroxyprogesterone acetate (Depo-Provera) was associated with a 53% increase in the risk...

How to Sign Up for the Depo-Provera Meningioma Lawsuits

Nov 23, 2024

If you or a loved one has been diagnosed with meningioma after using Depo-Provera, you may be entitled to pursue legal action. Anapol Weiss, a nationally recognized personal injury law firm, has long been a leader in mass tort claims against some of the largest pharmaceutical companies, including Johnson & Johnson and Pfizer. In October, Anapol Weiss filed one of the first complaints specifically alleging that Depo-Provera, manufactured by Pfizer, caused the development of meningiomas...

A Guide to the History of Depo-Provera

Nov 21, 2024

Depo-Provera, a widely used injectable contraceptive, has a long and complex history of development, medical applications, and controversies. Initially hailed as a breakthrough in birth control, its use has been clouded by numerous studies and global debates about its safety. Recent developments, including a 2024 study linking long-term Depo-Provera use to an increased risk of meningiomas, have raised new questions about its safety. The Discovery of Medroxyprogesterone Acetate Depo-Provera’s active ingredient, medroxyprogesterone acetate (MPA), was first synthesized...

U.S. News and The Guardian Report: Depo-Provera Associated with an Increased Risk of Tumors

Oct 28, 2024

The excerpts below from The Guardian and U.S. News provide essential information about the French study, announced in March 2024, that found an increased risk of brain and spinal cord tumors to be associated with prolonged Depo-Provera use. The study is referenced in lawsuits filed against Depo-Provera’s manufacturer, Pfizer. Anapol Weiss filed its first complaint against Pfizer on October 28, 2024, on behalf of a California woman who used Depo-Provera over a prolonged period and...

Depo-Provera: Most Recent In a Long Line of Litigation Against Unsafe Birth Control Products

Oct 14, 2024

Birth control has been a revolutionary development for women’s reproductive health and autonomy. However, some forms of birth control have also come with serious risks, leading to a wave of lawsuits against manufacturers over the years. From the notorious Dalkon Shield in the 1980s to the more recent Depo-Provera litigation (related to the product’s increased risk of causing brain and spinal cord tumors), the legal landscape surrounding birth control devices and drugs has been fraught...

A Lifetime of Legal Battles Against Dangerous Products

Oct 10, 2024

Tracy Finken Magnotta, Anapol Weiss Women’s Health Ligitation Team I Have Spent My Career Holding Companies Accountable for Marketing Unsafe Products and Failing to Disclose the Serious Risks to Consumers However, time and again, we see these companies prioritizing profits over safety. Billion-dollar products are marketed without proper warnings and the result is often catastrophic. Over the past 25 years, I have been passionate about representing women and children for the life-changing injuries they have sustained and...

Tumors May Be Among the Side Effects of Depo-Provera Use: How to File a Lawsuit

Oct 9, 2024

Depo-Provera (medroxyprogesterone acetate), a long-acting contraceptive injection, is used by millions of women worldwide. While exact numbers can vary by region and over time, as of recent estimates: Global use: Around 20 million women worldwide have used Depo-Provera. United States: Approximately 1.6 million women use Depo-Provera in the U.S. annually. This accounts for about 3% of women using contraception in the country. Depo-Provera Side Effects and Meningiomas Depo-Provera is especially popular due to its convenience (one injection every three...